文献速递其他结缔组织病

系统性硬化症器官损伤与死亡率的病理学贡献因素:一项全国配对病例对照研究

Pathological contributors to organ damage and mortality in systemic sclerosis: a nationwide matched case-control study.
PubMed 文献 · Semin Arthritis Rheum · 2025-04-29

该配对病例对照研究利用澳大利亚全国尸检数据,比较59例系统性硬化症(SSc)病例与59例年龄性别匹配对照的心脏、肺和肾脏组织病理学。SSc组心肌纤维化、炎症和小血管病变均显著更常见,且约三分之一至近半数器官存在多种并发病理。

要点

  • SSc组心肌纤维化风险为对照的11倍(95%CI 4-29,p<0.01),炎症为39倍(95%CI 2-672,p=0.01)。
  • SSc组小血管病变为对照的27倍(95%CI 2-485,p=0.02),但心外膜冠状动脉疾病无差异(p=0.24)。
  • SSc病例中31%心脏、41%肺、45%肾脏同时存在≥2种纤维化、炎症或血管病变。

核心结论

  • SSc中高频不明原因心肌纤维化为其超额死亡率和心脏性猝死机制提供线索。
  • 该配对尸检研究显示SSc器官损伤机制复杂,30-45%的器官存在多种并发病理。

研究设计与样本

  • 采用澳大利亚国家验尸信息系统尸检数据的配对病例对照研究。
  • SSc病例经关键词检索选取,并按年龄和性别与车祸对照匹配。
  • 提取死因、生前合并症和尸检发现,计算比值比(OR)及95%置信区间(CI)。
  • 共纳入59例SSc病例(64岁,81%女性)与59例对照(62岁,81%女性)。

主要发现

  • SSc组心肌纤维化为对照的11倍(95%CI 4-29,p<0.01),炎症为39倍(95%CI 2-672,p=0.01),小血管病变为27倍(95%CI 2-485,p=0.02)。
  • 心外膜冠状动脉疾病在两组间无差异(p=0.24)。
  • 三分之二SSc病例的心肌纤维化无可识别的继发原因(如冠状动脉/瓣膜病变)。
  • SSc组肺纤维化、炎症和血管病变为对照的23至100倍;肾纤维化/瘢痕、炎症/浸润和血管病变为对照的3至6倍。
  • SSc病例中同时存在≥2种纤维化、炎症或血管病变的比例:心脏31%、肺41%、肾脏45%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mortality is increased in systemic sclerosis (SSc), including a 10-15-fold increase in sudden cardiac death. Limited histopathology data exist to understand the pathogenesis of this excess. This study aimed to compare heart, lung and renal histopathology at autopsy between SSc and controls. METHODS: A matched case-control study was performed using autopsy data from the Australian National Coronial Information System. SSc cases were selected via keyword search, and age- and sex-matched to controls identified from motor vehicle accidents. Cause of death, antemortem comorbidities and autopsy findings were extracted. Odds ratios were calculated with 95 % confidence intervals (CI). FINDINGS: Fifty-nine SSc cases (64 years, 81 % female) were matched to 59 controls (62 years, 81 % female). Myocardial fibrosis was 11-times more common in SSc (95 %CI 4-29, p < 0.01), inflammation 39-times more common (95 %CI 2-672, p = 0.01) and small vessel vasculopathy 27-times more common (95 %CI 2-485, p = 0.02), despite no difference in epicardial coronary artery disease (p = 0.24). Two-thirds of SSc cases had myocardial fibrosis with no identifiable secondary cause (e.g., coronary/valvular lesions). Pulmonary fibrosis, inflammation and vasculopathy ranged from 23 to 100-times more common in SSc. Renal fibrosis/scarring, inflammation/infiltrates and vasculopathy were 3-6-times more common in SSc. Among SSc cases, combined pathologies (≥2 of fibrosis, inflammation or vasculopathy) were seen concurrently in 31 % of hearts, 41 % of lungs and 45 % of kidneys. INTERPRETATION: The high frequency of unexplained myocardial fibrosis in SSc provides insights into the mechanism of excess mortality and sudden cardiac death observed in SSc. This matched autopsy study demonstrates the mechanisms and complexity of organ damage in SSc, with 30-45 % of organs displaying multiple concurrent pathologies.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Fairley JL, Ross L, Paratz E, et al. Pathological contributors to organ damage and mortality in systemic sclerosis: a nationwide matched case-control study. Semin Arthritis Rheum. 2025. PMID: 40344933. doi:10.1016/j.semarthrit.2025.152739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。